Letter by Potter and Le Lorier Regarding Article, "Cardiovascular Outcomes and Mortality in Patients Using Clopidogrel With Proton Pump Inhibitors After Percutaneous Coronary Intervention or Acute Coronary Syndrome"

被引：1
|
作者：
Potter, Brian J. [1 ]
Le Lorier, Jaques [1 ]
机构：
[1] CHU Montreal, Ctr Rech, Pharmacoecon & Pharmacoepidemiol Res Unit, Montreal, PQ, Canada
来源：
CIRCULATION | 2010年 / 122卷 / 05期
关键词：
D O I：
10.1161/CIRCULATIONAHA.110.939991
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E414 / E414
页数：1
相关论文
共 50 条
  • [41] Risk of Adverse Outcomes Associated With Concomitant Use of Clopidogrel and Proton Pump Inhibitors Following Acute Coronary Syndrome
    Ho, P. Michael
    Maddox, Thomas M.
    Wang, Li
    Fihn, Stephan D.
    Jesse, Robert L.
    Peterson, Eric D.
    Rumsfeld, John S.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (09): : 937 - 944
  • [42] Efficacy and safety of proton pump inhibitors combined with clopidogrel in patients undergoing percutaneous coronary intervention: a meta-analysis
    Han, Yao-Yao
    Li, Zheng-Xiang
    Duan, Rong
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2021, 22 (01) : 167 - 174
  • [43] Proton Pump Inhibitors Increase Major Adverse Cardiac Events Among Post Percutaneous Coronary Intervention Patients on Clopidogrel
    Ching, Gilbert
    Li, Dadong
    McKay, Raymond
    Mather, Jeffrey
    Lundbye, Justin
    CIRCULATION, 2009, 120 (18) : S936 - S937
  • [44] Effects of Peri-Interventional High Clopidogrel Dose on the Outcomes of Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients With Low Response to Clopidogrel
    Jia Xinwei
    Fu Xianghua
    Gu Xinshun
    Pan Huanjun
    Fan Weize
    Zhang Jing
    Wang Zhanqi
    Wu Weili
    Li Shiqiang
    Hao Guozhen
    CIRCULATION, 2010, 122 (02) : E42 - E42
  • [45] Ticagrelor vs Clopidogrel for Patients With Acute Coronary Syndrome Undergoing Percutaneous Intervention
    Kim, Hyun Kuk
    Kubica, Jacek
    Jeong, Young-Hoon
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (09): : 890 - 890
  • [46] Residual Dyslipidemia Leads to Unfavorable Outcomes in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention
    Que, Bin
    Wang, Chunmei
    Ai, Hui
    Zhang, Xinyong
    Wang, Mei
    Nie, Shaoping
    STEM CELLS INTERNATIONAL, 2016, 2016
  • [47] Impact of CCBs on the Clinical Outcomes in Patients with Clopidogrel After Percutaneous Coronary Intervention
    Du, Meng-Yang
    Yuan, Jinqing
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (15) : S65 - S65
  • [48] Efficacy of Cilostazol in Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention
    Hu, Taohong
    Ma, Huili
    Li, Huijun
    Ren, Jianghua
    AMERICAN JOURNAL OF THERAPEUTICS, 2013, 20 (02) : 151 - 153
  • [49] Myocardial damage after percutaneous coronary intervention in patients with acute coronary syndrome
    Pascual, M
    Gomez-Hospital, JA
    Costello, JG
    Iraculis, E
    Teruel, LM
    Fernandez, SL
    Cequier, A
    Esplugas, E
    EUROPEAN HEART JOURNAL, 2004, 25 : 236 - 236
  • [50] Sex disparities for clinical outcomes after percutaneous coronary intervention for acute coronary syndrome
    Sterpetti, Antonio V.
    Gabriele, Raimondo
    Di Marzo, Luca
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2024, 404
12345